532605 Sigma-AldrichAurora A/MYCN Dual Inhibitor, CD532 - CAS 1639009-81-6 - Calbiochem
A cell permeable, highly potent, selective inhibitor of Aurora A (IC₅₀ = 48 nM). Disrupts MYCN-Aurora A complex.
More>> A cell permeable, highly potent, selective inhibitor of Aurora A (IC₅₀ = 48 nM). Disrupts MYCN-Aurora A complex. Less<<Synonyms: Aurora A Inhibitor, CD532, MYCN Inhibitor, CD532
Recommended Products
Overview
| Replacement Information | 
|---|
Key Spec Table
| CAS # | Empirical Formula | 
|---|---|
| 1639009-81-6 | C₂₆H₂₅F₃N₈O | 
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 5.32605.0001 | 
  |  
Glass bottle | 10 mg | 
  | 
— | 
| References | |
|---|---|
| References | Lee, J.K., et al. 2016. Cancer Cell. 29, In press. Gustafson, W. C., et al. 2014. Cancer Cell. 26, 414.  | 
| Product Information | |
|---|---|
| CAS number | 1639009-81-6 | 
| Form | Tan solid | 
| Hill Formula | C₂₆H₂₅F₃N₈O | 
| Chemical formula | C₂₆H₂₅F₃N₈O | 
| Reversible | Y | 
| Quality Level | MQ100 | 
| Applications | 
|---|
| Biological Information | |
|---|---|
| Primary Target | Aurora A | 
| Primary Target IC<sub>50</sub> | 48 nM | 
| Secondary target | MYCN | 
| Purity | ≥97% by HPLC | 
| Physicochemical Information | |
|---|---|
| Cell permeable | Y | 
| Dimensions | 
|---|
| Materials Information | 
|---|
| Toxicological Information | 
|---|
| Safety Information according to GHS | 
|---|
| Safety Information | 
|---|
| Product Usage Statements | 
|---|
| Packaging Information | |
|---|---|
| Packaged under inert gas | Packaged under inert gas | 
| Transport Information | 
|---|
| Supplemental Information | 
|---|
| Specifications | 
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN | 
| 5.32605.0001 | 04055977281804 | 
Documentation
Aurora A/MYCN Dual Inhibitor, CD532 - CAS 1639009-81-6 - Calbiochem SDS
| Title | 
|---|
References
| Reference overview | 
|---|
| Lee, J.K., et al. 2016. Cancer Cell. 29, In press. Gustafson, W. C., et al. 2014. Cancer Cell. 26, 414.  | 
Technical Info
| Title | 
|---|
| Characterization of Estrogen Receptor α Phosphorylation Sites in Breast Cancer Tissue Using the SNAP i.d® 2.0 System | 
| White Paper: Further considerations of antibody validation and usage. | 



  
